MedPath

TRUQAP

TRUQAP

Approved
DIN Number

02544741

Drug Class

Human

Market Date

Apr 1, 2024

Company
HC

astrazeneca canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02544741
AIG Number0165703002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX27 CAPIVASERTIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CAPIVASERTIBActive
Strength: 200 MG
Monograph: CAPIVASERTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.